Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aims to address these gaps by evaluating vitamin D levels and VDR polymorphisms and their association with clinical and biological outcomes in patients hospitalized with severe influenza and COVID-19 during the 2023 to 2024 winter season.

Source: 1. Introduction. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Results: A total of 71 patients were included in this cross-sectional study.

Source: Abstract.

Results: A total of 71 patients were included in this cross-sectional study.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Exploring the Association of Vitamin D and VDR Polymorphisms with Disease Severity in COVID-19 and Influenza

Cross-sectional study · Biomedicines · 2025

Original publication title

Exploring the Association of Vitamin D and VDR Polymorphisms with Disease Severity in COVID-19 and Influenza

Alexandru Constantin Sîrbu; Ioana Corina Bocșan; Octavia Sabin; Raluca Maria Pop; Ștefan Cristian Vesa; Gavriela Feketea; Violeta Briciu; Mihaela Lupșe; Anca Dana Buzoianu

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

Respiratory viral infections such as COVID-19 and influenza represent significant public health threats, especially in vulnerable populations. Vitamin D has been promoted as an immunomodulatory agent, with previous studies suggesting an association between vitamin D levels and disease severity in respiratory infections. Additionally, genetic variations in the vitamin D receptor (VDR) may influence immune responses.

Methods:

This study investigates the relationship between vitamin D levels, VDR polymorphisms (rs1544410, rs731236, and rs7975232), and clinical severity in hospitalized patients with COVID-19 and influenza during the 2023 to 2024 winter season.

Results:

A total of 71 patients were included in this cross-sectional study. Vitamin D levels were significantly lower in severe COVID-19 cases (8.08 ng/mL, IQR: 4.79 to 15.7) compared to moderate forms (32.6 ng/mL, IQR: 13.0 to 38.6), as well as severe influenza cases (25.6 ng/mL, IQR: 18.9 to 34.5). Additionally, severe COVID-19 patients exhibited higher inflammatory markers (CRP, neutrophil count) and lower lymphocyte counts. However, no significant association was found between VDR polymorphisms and disease severity or vitamin D levels.

Conclusions:

These findings highlight the potential role of vitamin D in modulating disease severity in respiratory viral infections, while the influence of genetic polymorphisms remains uncertain. Further research is needed to determine whether vitamin D supplementation could improve clinical outcomes in these infections.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Respiratory viral infections such as COVID-19 and influenza represent significant public health threats, especially in vulnerable populations. Vitamin D has been promoted as an immunomodulatory agent, with previous studies suggesting an association between vitamin D levels and disease severity in respiratory infections. Additionally, genetic variations in the vitamin D receptor (VDR) may influence immune responses.

Source: Background

Abstract: Results

A total of 71 patients were included in this cross-sectional study. Vitamin D levels were significantly lower in severe COVID-19 cases (8.08 ng/mL, IQR: 4.79 to 15.7) compared to moderate forms (32.6 ng/mL, IQR: 13.0 to 38.6), as well as severe influenza cases (25.6 ng/mL, IQR: 18.9 to 34.5). Additionally, severe COVID-19 patients exhibited higher inflammatory markers (CRP, neutrophil count) and lower lymphocyte counts. However, no significant association was found between VDR polymorphisms and disease severity or vitamin D levels.

Source: Results

Abstract: Conclusions

These findings highlight the potential role of vitamin D in modulating disease severity in respiratory viral infections, while the influence of genetic polymorphisms remains uncertain. Further research is needed to determine whether vitamin D supplementation could improve clinical outcomes in these infections.

Source: Conclusions
Authors’ abstract

Background:

Respiratory viral infections such as COVID-19 and influenza represent significant public health threats, especially in vulnerable populations. Vitamin D has been promoted as an immunomodulatory agent, with previous studies suggesting an association between vitamin D levels and disease severity in respiratory infections. Additionally, genetic variations in the vitamin D receptor (VDR) may influence immune responses.

Methods:

This study investigates the relationship between vitamin D levels, VDR polymorphisms (rs1544410, rs731236, and rs7975232), and clinical severity in hospitalized patients with COVID-19 and influenza during the 2023 to 2024 winter season.

Results:

A total of 71 patients were included in this cross-sectional study. Vitamin D levels were significantly lower in severe COVID-19 cases (8.08 ng/mL, IQR: 4.79 to 15.7) compared to moderate forms (32.6 ng/mL, IQR: 13.0 to 38.6), as well as severe influenza cases (25.6 ng/mL, IQR: 18.9 to 34.5). Additionally, severe COVID-19 patients exhibited higher inflammatory markers (CRP, neutrophil count) and lower lymphocyte counts. However, no significant association was found between VDR polymorphisms and disease severity or vitamin D levels.

Conclusions:

These findings highlight the potential role of vitamin D in modulating disease severity in respiratory viral infections, while the influence of genetic polymorphisms remains uncertain. Further research is needed to determine whether vitamin D supplementation could improve clinical outcomes in these infections.

Publication and source details

Original title: Exploring the Association of Vitamin D and VDR Polymorphisms with Disease Severity in COVID-19 and Influenza

Alexandru Constantin Sîrbu; Ioana Corina Bocșan; Octavia Sabin; Raluca Maria Pop; Ștefan Cristian Vesa; Gavriela Feketea; Violeta Briciu; Mihaela Lupșe; Anca Dana Buzoianu

Biomedicines · 2025

* Correspondence: bocsan.corina@umfcluj.ro© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:55:52.488461+00:00

DOI: 10.3390/biomedicines13112617 · PMC12650269